FIELD: narcology. SUBSTANCE: patient undergoes combined clinical examination and solid- phase enzymatic immunoassay of blood serum to determine level of immunoreactivity of autoantibodies to brain protein HB-GAM from optical density of reaction products, and, when this level lowers more than by 35% as compared to average immunoreactivity level in healthy persons, opium drug addiction is diagnosed. EFFECT: improved accuracy and objectivity of diagnostics.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING CHRONIC ALCOHOLIC INTOXICATION | 2001 |
|
RU2204136C2 |
| METHOD OF TREATMENT OF ALCOHOLICS | 1996 |
|
RU2136295C1 |
| METHOD OF DIAGNOSING DESOMORPHINE DEPENDENCE IN PATIENTS WITH THERMAL BURNS | 2011 |
|
RU2452362C1 |
| TEST SYSTEM FOR DETECTING OPIUM NARCOMANIA | 2001 |
|
RU2193199C1 |
| METHOD OF METHADONE DETERMINATION IN BIOLOGICAL FLUIDS | 1997 |
|
RU2137135C1 |
| METHOD FOR PREDICTING OPIUM NARCOMANIA AND ITS DURATION | 2002 |
|
RU2221251C1 |
| METHOD FOR DIAGNOSING THE CASES OF PATHOLOGICAL ATTRACTION TO ALCOHOL CONSUMPTION | 1996 |
|
RU2139674C1 |
| METHOD OF ARRESTING OF OPIUM ABSTINENCE | 1996 |
|
RU2135172C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF ABSTINENCE SYMPTOMS IN CASE OPIUM ADDICTION COMBINED WITH HIV INFECTION | 2016 |
|
RU2646478C1 |
| METHOD OF NEUROIMAGING DIAGNOSTICS OF OPIOID ADDICTION | 2023 |
|
RU2806489C1 |
